Drug intelligence / Profile preview

human albumin + propofol

Development stage
Unknown
Lead developer
University of California, San Diego
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Intravenous
01

Overview

Human albumin + propofol is an experimental diagnostic contrast agent mixture developed by researchers at the University of California, San Diego for use in transesophageal echocardiography (TEE) bubble studies. The mixture, typically composed of 7 mL of 5% human albumin and 3 mL of propofol (10 mg/mL), is agitated to create stable microbubbles that provide superior ultrasound contrast compared to standard agitated saline. While human albumin is traditionally used as a plasma expander and propofol as a sedative-hypnotic, this specific combination leverages their physical properties to enhance the visualization of cardiac shunts and other structural abnormalities during cardiac surgery. It is currently being evaluated in clinical trials (e.g., NCT02613052) to determine its efficacy and safety relative to traditional contrast agents.

Other names
human albumin + propofol-University of California, San Diegoalbumin-propofol mixturepropofol-albumin mixtureagitated albumin and propofol
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on human albumin + propofol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human albumin + propofol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call